Clinical Pharmacology · Hepatic and Nutrition Pharmacology
Hepatic Encephalopathy Medications
On this page 6 sections
In 30 seconds
Hepatic encephalopathy (HE) is brain dysfunction from a failing liver and portosystemic shunting that let gut-derived toxins like ammonia reach the brain. First-line treatment is lactulose, a nonabsorbable sugar that traps ammonia in the colon and flushes it out; rifaximin is often added to reduce ammonia-producing gut bacteria and prevent recurrence. Just as important is fixing whatever triggered the episode — bleeding, infection, constipation, dehydration, or sedatives. Protein restriction is outdated and no longer recommended.
The college version
Pathophysiology
A healthy liver converts ammonia and other nitrogenous byproducts of protein digestion into urea for renal excretion. In cirrhosis, hepatocyte function declines and portosystemic shunts let portal blood bypass the liver, so ammonia reaches the brain. Astrocytes convert ammonia to glutamine; excess glutamine draws water into these cells, causing cerebral swelling, while altered glutamate and GABA signaling disturbs neurotransmission. Clinically this ranges from subtle inattention and reversed sleep-wake patterns, through confusion and asterixis (a flapping hand tremor), to stupor and coma.
Lactulose, first-line therapy
Lactulose is a synthetic disaccharide human enzymes cannot digest, so it reaches the colon intact, where bacteria ferment it into acids. This converts absorbable ammonia (NH3) into non-absorbable ammonium (NH4+), trapping it for excretion. Lactulose also acts as an osmotic laxative, speeding transit and clearing nitrogenous waste before absorption. Because both effects matter, dosing is titrated to a clinical endpoint — typically two to three soft stools daily — not to comfort. Overshooting causes real harm: excessive stooling can cause dehydration and electrolyte disturbances that worsen encephalopathy, plus flatulence and cramping that hurt adherence. When a patient cannot swallow safely, lactulose can be given as a retention enema.
Rifaximin and adjuncts
Rifaximin is a poorly absorbed oral antibiotic that concentrates in the gut, reducing ammonia-producing bacteria; minimal absorption limits toxicity versus older agents. It is add-on therapy with lactulose to reduce recurrence, not monotherapy. Polyethylene glycol, the osmotic agent used for bowel prep, offers rapid catharsis in acute episodes. Older or adjunct options include neomycin (oto- and nephrotoxicity), metronidazole (peripheral neuropathy), L-ornithine L-aspartate (supports alternative ammonia-disposal pathways), and zinc, often deficient in cirrhosis and supportive of urea cycle function.
Treat the precipitant
Most episodes have an identifiable trigger; reversing it matters as much as any drug: GI bleeding (a protein load bacteria ferment), infection including spontaneous bacterial peritonitis, constipation, dehydration or overdiuresis, electrolyte disturbances, and sedatives or opioids a compromised liver cannot clear well. Protein restriction, once used to lower nitrogen load, is no longer recommended: cirrhotic patients are often malnourished, and adequate protein supports muscle mass that helps metabolize ammonia.

Eli explains
The same idea, in plain words
Explain it like I’m 10
Your body's kitchen (the liver) cleans up a messy byproduct called ammonia after every meal. If the kitchen breaks down, or pipes get rerouted around it, ammonia sneaks into your brain and makes everything foggy, like TV static. Lactulose is a sponge-broom for your gut: it soaks up ammonia and sweeps it out with extra bathroom trips — just enough trips to clean house, not so many you get dried out. Rifaximin is a smaller cleanup crew that kills the germs making the mess. None of this helps, though, if you don't also find why the mess started, like a hidden leak (bleeding) or a clog (constipation).
Check yourself
2 review questions from the chapter. Try each one, then open the answer.
A cirrhotic patient on a stable lactulose regimen develops new confusion after several days of poor oral intake and no bowel movements. What should be assessed and addressed before assuming the lactulose dose itself has failed?
Show answer
Constipation and dehydration as a new precipitant
No bowel movements for days suggests lactulose isn't reaching its stool-count target, so ammonia is likely building back up; poor intake also raises dehydration risk. Both need correction, plus checking for other triggers like infection, before assuming drug failure.
Why has protein restriction fallen out of favor in the dietary management of hepatic encephalopathy?
Show answer
Malnutrition risk outweighs the nitrogen-lowering benefit
Cirrhotic patients are often already malnourished and losing muscle, and muscle helps dispose of ammonia, so restricting protein worsens wasting without reliably improving encephalopathy — adequate protein intake is now preferred instead.
Quick check
3 questions here. Answers stay hidden until you check.
What is the correct way to titrate a patient's lactulose dose?
Which statement about rifaximin is accurate?
Study tools & related lessonsRelated
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.

